GUYER WILLIAM (Chief Development Officer) sold 83.4% of their position (20K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $1.86M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/8/2026ACC: 0001193125-26-298865
Officer· Chief Development Officer
Since Aug 2021
-20K
Net shares
Net seller
$1.86M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
20K acquired · 40K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+20K
Price / share
$21.65
Trade value
$433K
% of position
501.9%
7/7/2026
3.98K→23.98K
Common Stock
Direct
Shares
−19.05K
Price / share
$93.11
Trade value
$1.77M
% of position
79.4%
7/7/2026
23.98K→4.94K
Common Stock
Direct
Shares
−952.00
Price / share
$93.54
Trade value
$89.05K
% of position
19.3%
7/7/2026
4.94K→3.98K
Total
Net shares
+0.00
Net value
-$1.43M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/7/2026 | M · Option Exercise | +20K | $21.65 | $433K | 501.9% | 3.98K | 23.98K |
| Common Stock Direct | 7/7/2026 | S · Sale | −19.05K | $93.11 | $1.77M | 79.4% | 23.98K | 4.94K |
| Common Stock Direct | 7/7/2026 | S · Sale | −952.00 | $93.54 | $89.05K | 19.3% | 4.94K | 3.98K |
| Total | +0.00 | -$1.43M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
20K shares
Shares
−20K
Strike price
21.65
Held after
130K
Exercisable
—
7/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock20K shares | 7/7/2026 | M · Option Exercise | −20K | 21.65 | — | 130K |